Evidence map›Paper›PMID 35299865›Full record

ArticleInternational journal of nanomedicine2022

A Composite Deferoxamine/Black Phosphorus Nanosheet/Gelatin Hydrogel Scaffold for Ischemic Tibial Bone Repair.

Dingli Xu, Kaifeng Gan, Yang Wang, Zeting Wu, Yulong Wang, Song Zhang, Yujie Peng, Xuguang Fang, Hua Wei, Yansheng Zhang and 2 more

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Risk factors for proximal radial abnormalities in children with untreated chronic Monteggia fractures: a review of 142 cases.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Black Phosphorus Accelerates Bone Regeneration Based on Immunoregulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dingli Xu *The Affiliated Hospital of Ningbo University Medical School, Ningbo, 315000, People's Republic of China.ORCID 0000-0002-9046-0718
Kaifeng Gan *The Affiliated Lihuili Hospital of Ningbo University, Ningbo, 31500, People's Republic of China.
Yang WangThe Affiliated Hospital of Ningbo University Medical School, Ningbo, 315000, People's Republic of China.
Zeting WuThe Affiliated Hospital of Ningbo University Medical School, Ningbo, 315000, People's Republic of China.
Yulong WangThe Affiliated Hospital of Ningbo University Medical School, Ningbo, 315000, People's Republic of China.
Song ZhangThe Affiliated Hospital of Ningbo University Medical School, Ningbo, 315000, People's Republic of China.ORCID 0000-0001-6513-9861
Yujie PengNingbo No.6 Hospital, Ningbo, 315000, People's Republic of China.
Xuguang FangThe First Affiliated Hospital of Xi 'an Medical University, Xi'an, 710082, People's Republic of China.
Hua WeiZhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, People's Republic of China.ORCID 0000-0003-4103-463X
Yansheng ZhangZhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, People's Republic of China.
Weihu MaNingbo No.6 Hospital, Ningbo, 315000, People's Republic of China.
Jing ChenZhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, People's Republic of China.ORCID 0000-0002-0024-4561

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bone delay union is mostly caused by lack of blood supply. Although autografts, allografts and artificial bone have been widely used to treat bone delay union, the bone regeneration fails in the ischemic site accompanied by the bone donor site complications and disease transmission. Recently, there is a growing recognition of the importance of hydrogel scaffolds which are regarded as an eligible engineer tissue for bone repair. However, hydrogel is still limited in improving neovascularization. Methods: In this work, black phosphorus nanosheet and deferoxamine (BPN-DFO) were loaded in the gelatin hydrogel to overcome the high risk of bone delay union and systemically investigated the regeneration capability of BPN-DFO hydrogel in vitro and vivo. Results: The resulting BPN-DFO hydrogel scaffold showed superior swollen, degradation and release rate, as well as satisfied biocompatibility. BPN-DFO hydrogel shown the significant up-expression of mRNA related to bone regeneration and cell proliferation. In vivo, the proposed BPN-DFO hydrogel significantly improved osteogenesis and neovascularization in the ischemic tibial bone site of SD rats with acute femoral artery occlusion. Both macroscopic and histological evaluation of new regenerated bone showed newly formed blood vessel and collagen using BPN-DFO hydrogel. The immunohistochemistry and RT-PCR revealed that the bone regeneration could be improved via BMP/Runx2 pathway. Conclusion: The BPN-DFO hydrogel possesses potential tissue engineer material for ischemic bone defect treatment. However, furthermore studies are needed to testify the safety and efficacy of BPN-DFO hydrogel.

Indexed as

Bone RegenerationFracture HealingIschemiaNanostructuresTibiaTissue ScaffoldsAnimalsDeferoxamineGelatinHydrogelsPhosphorusRatsRats, Sprague-DawleyTissue EngineeringDeferoxamineGelatinHydrogelsPhosphorusblack phosphorus nanosheetsdeferoxaminehydrogel scaffoldsischemic bone defect regeneration

Identifiers

PMID35299865
PMCPMC8923703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.